Anti-GalNAcβ: A novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model

Journal of Autoimmunity

Volumn 39, Issue 4, 2012, Pages 420-427

  Blank, Miri ^a   Krause, Ilan ^a,b   Dotan, Nir ^c   Anafi, Liat ^a   Eisenstein, Miriam ^d   Cervera, Ricard ^e   Meroni, Pier Luigi ^f   Shoenfeld, Yehuda ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c Glycominds Ltd   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e HOSPITAL CLÍNIC   (Spain)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Autoimmunity; Experimental model; Galectins; Metalloproteinase

Indexed keywords

AUTOANTIBODY; GALNACBETA ANTIBODY; GELATINASE A; GELATINASE B; GLYCAN ANTIBODY; N ACETYL BETA DEXTRO GLUCOSAMINE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL INVASION; CELL PROLIFERATION; CHORIOCARCINOMA; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; FETUS WASTAGE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE;

ABORTION, SPONTANEOUS; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BIOLOGICAL ASSAY; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHORIOCARCINOMA; COLLAGEN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG COMBINATIONS; FEMALE; GALACTANS; HUMANS; INJECTIONS, INTRAVENOUS; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PREGNANCY; PROTEOGLYCANS; UTERINE NEOPLASMS;

EID: 84869868757     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.07.002     Document Type: Article

References (50)

1. Raman R., Raguram S., Venkataraman G., Paulson J.C., Sasisekharan R. Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat Methods 2005, 2:817-824.
2. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002, 125:2591-2625.
3. Watkins W.M. Blood-group substances. Science 1966, 152:172-181.
4. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005, 83:674-686.
5. McMorrow I.M., Comrack C.A., Sachs D.H., DerSimonian H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. Transplantation 1997, 64:501-510.
6. Menge T., Lalive P.H., von Budingen H.C., Cree B., Hauser S.L., Genain C.P. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis. J Allergy Clin Immunol 2005, 116:453-459.
7. Brettschneider J., Jaskowski T.D., Tumani H., Abdul S., Husebye D., Seraj H., et al. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. J Neuroimmunol 2009, 217:95-101.
8. Freedman M.S., Laks J., Dotan N., Altstock R.T., Dukler A., Sindic C.J. Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event. Mult Scler 2009, 15:422-430.
9. Vermeire S., Joossens S., Peeters M., Monsuur F., Marien G., Bossuyt X., et al. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001, 120:827-833.
10. Krause I., Monselise Y., Milo G., Weinberger A. Anti-Saccharomyces cerevisiae antibodies-a novel serologic marker for Behcet's disease. Clin Exp Rheumatol 2002, 20:S21-S24.
11. Blank M., Krause I., Magrini L., Spina G., Kalil J., Jacobsen S., et al. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford) 2006, 45:833-841.
12. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002, 46:1019-1027.
13. Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M.A. Antiphospholipid syndrome. Lancet 2010, 376:1498-1509.
14. Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003, 12:497-498.
15. Abrahams V.M. Mechanisms of antiphospholipid antibody-associated pregnancy complications. Thromb Res 2009, 124:521-525.
16. Alijotas-Reig J., Vilardell-Tarres M. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?. Obstet Gynecol Surv 2010, 65:39-45.
17. Meroni P.L., Borghi M.O., Raschi E., Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011, 7:330-339.
18. Martinez de la Torre Y., Pregnolato F., D'Amelio F., Grossi C., Di Simone N., Pasqualini F., et al. Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the beta2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. J Autoimmun 2011, [Epub ahead of print].
19. Di Simone N., Raschi E., Testoni C., Castellani R., D'Asta M., Shi T., et al. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Ann Rheum Dis 2005, 64:462-467.
20. Quenby S., Mountfield S., Cartwright J.E., Whitley G.S., Chamley L., Vince G. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 2005, 83:691-698.
21. Di Simone N., Meroni P.L., de Papa N., Raschi E., Caliandro D., De Carolis C.S., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000, 43:140-150.
22. D'Ippolito S., Di Simone N., Di Nicuolo F., Castellani R., Caruso A. Antiphospholipid antibodies: effects on trophoblast and endothelial cells. Am J Reprod Immunol 2007, 58:150-158.
23. Krause I., Blank M., Cervera R., Font J., Matthias T., Pfeiffer S., et al. Cross reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome. Ann N Y Acad Sci 2007, 1108:481-488.
24. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
25. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991, 88:3069-3073.
26. Blank M., Shoenfeld Y., Cabilly S., Heldman Y., Fridkin M., Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci U S A 1999, 96:5164-5168.
27. Goldman S., Weiss A., Eyali V., Shalev E. Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Mol Hum Reprod 2003, 9:367-373.
28. Gambino R., Ruiu G., Pagano G., Cassader M. Study of the glycosylation of apolipoprotein H. Chem Phys Lipids 1999, 103:161-174.
29. Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., Koike T. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994, 179:457-462.
30. de Laat B., Derksen R.H., van Lummel M., Pennings M.T., de Groot P.G. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood 2006, 107:1916-1924.
31. Hammel M., Kriechbaum M., Gries A., Kostner G.M., Laggner P., Prassl R. Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle X-ray scattering. J Mol Biol 2002, 321:85-97.
32. Kondo A., Miyamoto T., Yonekawa O., Giessing A.M., Osterlund E.C., Jensen O.N. Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome. J Proteomics 2009, 73:123-133.
33. d'Angeac A.D., Stefas I., Duperray C, Rucheton M., Graafland H., Montero J.L., et al. Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies. J Immunol Methods 2005, 300:160-178.
34. Dupuy D'Angeac A., Stefas I., Graafland H., De Lamotte F., Rucheton M., Palais C., et al. Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9. Biochem J 2006, 393:117-127.
35. Agostinis C., Biffi S., Garrovo C., Durigutto P., Lorenzon A., Bek A., et al. In vivo distribution of beta2 glycoprotein I under various pathophysiologic conditions. Blood 2011, 118:4231-4238.
36. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
37. Bischof P., Campana A. Trophoblast differentiation and invasion: its significance for human embryo implantation. Early Pregnancy 1997, 3:81-95.
38. Shah B.H., Catt K.J. Matrix metalloproteinases in reproductive endocrinology. Trends Endocrinol Metab 2004, 15:47-49.
39. Xu P., Alfaidy N., Challis J.R. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 2002, 87:1353-1361.
40. Jovanovic M., Stefanoska I., Radojcic L., Vicovac L. Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. Reproduction 2011, 139:789-798.
41. Staun-Ram E., Goldman S., Shalev E. p53 Mediates epidermal growth factor (EGF) induction of MMP-2 transcription and trophoblast invasion. Placenta 2009, 30:1029-1036.
42. Blank M., Anafi L., Zandman-Goddard G., Krause I., Goldman S., Shalev E., et al. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int Immunol 2007, 19:857-865.
43. Hirabayashi J., Hashidate T., Arata Y., Nishi N., Nakamura T., Hirashima M., et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 2002, 1572:232-254.
44. Dhirapong A., Lleo A., Leung P., Gershwin M.E., Liu F.T. The immunological potential of galectin-1 and -3. Autoimmun Rev 2009, 8:360-363.
45. Fitzgerald J.S., Germeyer A., Huppertz B., Jeschke U., Knofler M., Moser G., et al. Governing the invasive trophoblast: current aspects on intra- and extracellular regulation. Am J Reprod Immunol 2010, 63:492-505.
46. Fischer I., Schulze S., Kuhn C., Friese K., Walzel H., Markert U.R., et al. Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo. Placenta 2009, 30:1078-1082.
47. van der Leij J., van den Berg A., Blokzijl T., Harms G., van Goor H., Zwiers P., et al. Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. J Pathol 2004, 204:511-518.
48. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007, 13:1450-1457.
49. van den Brule F.A., Price J., Sobel M.E., Lambotte R., Castronovo V. Inverse expression of two laminin binding proteins, 67LR and galectin-3, correlates with the invasive phenotype of trophoblastic tissue. Biochem Biophys Res Commun 1994, 201:388-393.
50. Bozic M., Petronijevic M., Milenkovic S., Atanackovic J., Lazic J., Vicovac L. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 2004, 25:797-802.